ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Aktis Oncology Inc

Aktis Oncology Inc (AKTS)

27.88
-0.54
(-1.90%)
終了 7月12日 5:00AM
27.88
-0.01
(-0.04%)
取引時間後: 8:15AM

Aktis Oncology Inc (AKTS) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
27.88
( -1.90% )
買値
25.25
売値
44.79
出来高
487,232
平均取引量 (3 か月)
US$ 310,611
財務取引量
US$ 13,462,086
26.52 日の範囲 28.645
0.0372 52 週間の範囲 34.1899
時価総額
企業価値
941.262M
前日終値
28.42
始値
27.95
最終取引時間
VWAP
27.6297
歳入
8.28M
純利益
-67.07M
発行済株式数
55,277,447
浮動株比率 (%)
50.93%
機関投資家保有比率 (%)
79.75%
配当利回り
PER
-5.06
株価売上高倍率 (PSR)
177.38
1 株当たり利益 (EPS)
-5.25
ベータ
-

Aktis Oncology Inc について

Aktis Oncology, Inc., a clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharmaceuticals to treat various solid tumor cancers. The company’s lead product candidate includes [225Ac]Ac-AKY-1189, a miniprotein radioconjugate platform which is... Aktis Oncology, Inc., a clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharmaceuticals to treat various solid tumor cancers. The company’s lead product candidate includes [225Ac]Ac-AKY-1189, a miniprotein radioconjugate platform which is in ongoing Phase 1b clinical trial for the treatment of Nectin-4 expressing solid tumors, including locally advanced or metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and [225Ac]Ac-AKY-2519 to deliver 225Ac to B7-H3 (CD276) expressing tumors, including prostate, lung and other solid tumors. It has license and collaboration agreements with Protein Innovation, Inc., TRIUMF Innovations, Inc., and Eli Lilly. The company was formerly known as HotKnot Therapeutics, Inc. and changed its name to Aktis Oncology, Inc. in April 2020. Aktis Oncology, Inc. was incorporated in 2020 and is headquartered in Boston, Massachusetts. 詳細を表示

セクター
Health Care
業界
-
ウェブサイト
本社
Boston, United States
設立
2026
Aktis Oncology Inc is listed in the Health Care sector of the ナスダック市場 with ticker AKTS. The last closing price for Aktis Oncology was US$28.42. Over the last year, Aktis Oncology shares have traded in a share price range of US$ 0.0372 to US$ 34.1899.

Aktis Oncology currently has 55,277,447 shares in issue. The market capitalisation of Aktis Oncology is US$1.54 billion. Aktis Oncology has a price to earnings ratio (PE ratio) of -5.06.

AKTS 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-3.87-12.18897637831.7532.3825.8461413327.66037276CS
46.5230.524344569321.3634.189920.565270527.72600946CS
128.8846.73684210531934.189917.8832942624.74592174CS
265.4324.187082405322.4534.189914.7231358021.76400853CS
5227.842874846.23655910.037234.18990.037215366721.76400853CS
15625.11906.4981949462.7734.18990.03339609960.46132541CS
26017.86178.24351297410.0234.18990.03325887790.83308069CS

AKTS - Frequently Asked Questions (FAQ)

What is the current Aktis Oncology Inc share price?
The current share price of Aktis Oncology Inc is US$ 27.88
How many Aktis Oncology Inc shares are in issue?
Aktis Oncology Inc has 55,277,447 shares in issue
What is the market cap of Aktis Oncology Inc?
The market capitalisation of Aktis Oncology Inc is USD 1.54B
What is the 1 year trading range for Aktis Oncology Inc share price?
Aktis Oncology Inc has traded in the range of US$ 0.0372 to US$ 34.1899 during the past year
What is the PE ratio of Aktis Oncology Inc?
The price to earnings ratio of Aktis Oncology Inc is -5.06
What is the cash to sales ratio of Aktis Oncology Inc?
The cash to sales ratio of Aktis Oncology Inc is 177.38
What is the registered address of Aktis Oncology Inc?
The registered address for Aktis Oncology Inc is 17 Drydock Avenue, Boston, Massachusetts, 02210
What is the Aktis Oncology Inc website address?
The website address for Aktis Oncology Inc is www.aktisoncology.com

AKTS 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

AKTS Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock